Botanix Pharmaceuticals Limited (BXPHF)
Botanix Pharmaceuticals Limited operates in the Biotechnology industry of the Healthcare sector, headquartered in Melbourne, VIC, AU. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $29.8M. On trailing twelve-month figures it carries a trailing P/E of -0.56, a net margin of -202.2%. Its beta of 0.86 implies it has historically moved less than the broad market.
Botanix Pharmaceuticals Ltd is a dermatology company that focuses on developing safe and effective topical treatments for serious skin conditions. The company's product pipeline includes treatments for conditions such as moderate to severe acne, atopic dermatitis, rosacea, and axillary hyperhidrosis. It has an exclusive license to use a proprietary drug delivery system for skin diseases.
Botanix Pharmaceuticals Limited is most often compared with the following Healthcare names: